386 results
How do clinicians discuss aducanumab with their patients with Alzheimer disease given the less than positive evidence behind the FDA accelerated approval? DynaMed’s Deputy Editor of Neurology weighs in.
SARS-CoV-2 variants of concern (VOC) are circulating around the globe. Here’s what you need to know about Alpha, Beta, Gamma, and Delta variants.
Gender-affirming surgery is associated with improved mental health outcomes among transgender and gender diverse (TGD) people. Read about new evidence in this EBM Focus article.
Is a hospital-at-home model with comprehensive geriatric assessment (CGA) an alternative to hospital admission for older adults? Read this EBM Focus article to find out.
With the rising number of antitransgender bills aiming to limit care for transgender adolescents, DynaMed® editors evaluate the science behind gender-affirming care for transgender youth.
Insulin therapy should be considered for patients with type 2 diabetes who are unable to maintain glycemic goals with diet and glucose-lowering medications.
Durability of immunity and risk of reinfection with SARS-CoV-2 is an important area of research, but what do the studies actually tell us about protection against COVID-19?
A new study suggests lower blood pressure goals may be appropriate for cardiovascular risk reduction in women compared to men, but does data really support it?
What global health issues should we keep an eye on in 2021? Dr. Stephen A. Berger co-founder of GIDEON (Global Infectious Diseases and Epidemiology Network) outlines five candidates that may re-emerge post-pandemic.
All patients with type 1 diabetes require life-long insulin due to absent or near-absent beta-cell function. Insulin therapy in patients with type 1 diabetes should ideally be managed with an endocrinologist.